The effect of G-CSF on the composition of human bone marrow

被引:8
作者
Tegg, EM [1 ]
Tuck, DM [1 ]
Lowenthal, RM [1 ]
Marsden, KA [1 ]
机构
[1] Royal Hobart Hosp, Clin Haematol & Med Oncol Unit, Hobart, Tas 7001, Australia
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 1999年 / 21卷 / 04期
关键词
bone marrow; G-CSF; morphology;
D O I
10.1046/j.1365-2257.1999.00227.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects on bone marrow cellularity and morphology of 6 days' treatment with granulocyte colony-stimulating factor (G-CSF) in 35 patients were studied. Examination of trephine biopsies showed a highly significant increase in cellularity (P < 10(-13)). Assessment of aspirates revealed an increase in the myeloid to erythroid (M : E) ratio (P = 0.00006), the proportion of myeloid cells (P < 10(-8)), myelocytes (P = 0.00007), metamyelocytes (P = 0.04), band forms (P = 0.0005) and neutrophils (P = 0.02). This study presents a comprehensive analysis of the effects of six days' administration of G-CSF on human bone marrow.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 50 条
  • [21] Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
    Meritxell Nomdedeu
    María Carmen Lara-Castillo
    Amaia Etxabe
    Josep María Cornet-Masana
    Marta Pratcorona
    Marina Díaz-Beyá
    Xavier Calvo
    María Rozman
    Dolors Costa
    Jordi Esteve
    Ruth M. Risueño
    Cancer Cell International, 15
  • [22] Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
    Nomdedeu, Meritxell
    Carmen Lara-Castillo, Maria
    Etxabe, Amaia
    Maria Cornet-Masana, Josep
    Pratcorona, Marta
    Diaz-Beya, Marina
    Calvo, Xavier
    Rozman, Maria
    Costa, Dolors
    Esteve, Jordi
    Risueno, Ruth M.
    CANCER CELL INTERNATIONAL, 2015, 15
  • [23] Exclusive expression of G-CSF receptor on myeloid progenitors in bone marrow CD34+ cells
    Ebihara, Y
    Xu, MJ
    Manabe, A
    Kikuchi, A
    Tanaka, R
    Kato, S
    Nakahata, T
    Tsuji, K
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) : 153 - 161
  • [24] Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells
    Huber, Bruno C.
    Beetz, Nick L.
    Laskowski, Alexandra
    Ziegler, Tilman
    Grabmaier, Ulrich
    Kupatt, Christian
    Herbach, Nadja
    Wanke, Ruediger
    Franz, Wolfgang-Michael
    Massberg, Steffen
    Brunner, Stefan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (05) : 1033 - 1041
  • [25] THE EFFECT OF CONTINUOUS G-CSF APPLICATION IN HUMAN CYCLIC NEUTROPENIA - A MODEL ANALYSIS
    SCHMITZ, S
    FRANKE, H
    WICHMANN, HE
    DIEHL, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) : 41 - 47
  • [26] ABSENCE OF STIMULATORY EFFECT OF G-CSF ON THE GROWTH OF HUMAN SARCOMA-CELLS
    MANARA, MC
    SCOTLANDI, K
    SERRA, M
    MAURICI, D
    SARTI, M
    CAMPANACCI, M
    BALDINI, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (05) : 1011 - 1014
  • [27] Effect of continuous intravenous administration of high-dose G-CSF on hematologic recovery following autologous purged bone marrow transplantation
    Tanikawa, S
    Sakamaki, H
    Akiyama, H
    Onozawa, Y
    Kaku, H
    Sasaki, T
    Takamoto, S
    Adachi, Y
    Nara, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (06) : 1355 - 1361
  • [28] Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF
    T Ozcelik
    P Topcuoglu
    M Beksac
    M Ozcan
    M Arat
    Z Bıyıklı
    S M Bakanay
    O Ilhan
    G Gurman
    O Arslan
    T Demirer
    Bone Marrow Transplantation, 2009, 44 : 779 - 783
  • [29] Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF
    Ozcelik, T.
    Topcuoglu, P.
    Beksac, M.
    Ozcan, M.
    Arat, M.
    Biyikli, Z.
    Bakanay, S. M.
    Ilhan, O.
    Gurman, G.
    Arslan, O.
    Demirer, T.
    BONE MARROW TRANSPLANTATION, 2009, 44 (12) : 779 - 783
  • [30] Ghrelin therapy mitigates bone marrow injury and splenocytopenia by sustaining circulating G-CSF and KC increases after irradiation combined with wound
    Kiang, Juliann G.
    Anderson, Marsha N.
    Smith, Joan T.
    CELL AND BIOSCIENCE, 2018, 8